Literature DB >> 31806963

Carrier-Free, Dual-Functional Nanorods Via Self-Assembly Of Pure Drug Molecules For Synergistic Chemo-Photodynamic Therapy.

Yuping Zhao1, Yanna Zhao1, Qisan Ma1, Bin Sun1, Qingpeng Wang1, Zhuang Ding1, Huaizhen Zhang2, Xiuling Chu3, Min Liu1, Zhengping Wang1, Jun Han1.   

Abstract

BACKGROUND: The combination of chemo-photodynamic therapy based on nano-technology has emerged as a preferable and promising measure for synergetic antitumor therapy.
PURPOSE: The aim of this study was expected to overcome most of the safety concerns from nano-carriers and improve the chemo-photodynamic synergistic antitumor efficacy.
METHODS: Herein, we reported a facile and effective approach based on the self-assembly of chemotherapeutic agent 10-hydroxycamptothecin (HCPT) and photosensitizer chlorin e6 (Ce6) for preparing stably dual-functional nanorods (NRs).
RESULTS: The chemical thermodynamic parameters obtained from isothermal titration calorimeter (ITC) and the microcosmic configuration snapshots acquired by molecular dynamics (MD) simulations verified that HCPT and Ce6 molecules tended to assemble with each other through various intermolecular forces. The as-prepared HCPT/Ce6 NRs possessed a relatively uniform size of around 165 nm and zeta potential of about -29 mV, together with good stability in aqueous solution and freeze-dried state. In addition, both the extra- and intracellular reactive oxygen species (ROS) generation capacity of the NRs under laser irradiation was significantly enhanced compared with Ce6 injections. Moreover, the dual-functional HCPT/Ce6 NRs exhibited a substantial in vitro/in vivo synergistic antitumor efficacy under laser irradiation due to the integration of the two therapeutic modalities into one drug delivery system. Besides, no obvious hepatic or renal toxicity was observed in the NRs treatment groups.
CONCLUSION: Taken together, HCPT/Ce6 NRs demonstrated a powerful efficacy in chemo-photodynamic therapy for breast cancer. Therefore, the carrier-free dual-functional NRs prepared in a facile and effective strategy might give inspiration for the development of combined antitumor therapy.
© 2019 Zhao et al.

Entities:  

Keywords:  carrier-free; chemo-photodynamic; combined antitumor therapy; dual-functional nanorods; self-assembly; synergistic antitumor efficacy

Mesh:

Substances:

Year:  2019        PMID: 31806963      PMCID: PMC6842288          DOI: 10.2147/IJN.S224704

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  51 in total

1.  Shape design of high drug payload nanoparticles for more effective cancer therapy.

Authors:  Wei Li; Xiujuan Zhang; Xiaojun Hao; Jiansheng Jie; Baishun Tian; Xiaohong Zhang
Journal:  Chem Commun (Camb)       Date:  2013-12-04       Impact factor: 6.222

2.  Supramolecular "Trojan Horse" for Nuclear Delivery of Dual Anticancer Drugs.

Authors:  Yanbin Cai; Haosheng Shen; Jie Zhan; Mingliang Lin; Liuhan Dai; Chunhua Ren; Yang Shi; Jianfeng Liu; Jie Gao; Zhimou Yang
Journal:  J Am Chem Soc       Date:  2017-02-14       Impact factor: 15.419

3.  Photosensitizer-Loaded Branched Polyethylenimine-PEGylated Ceria Nanoparticles for Imaging-Guided Synchronous Photochemotherapy.

Authors:  Zhang-You Yang; Hong Li; Yi-Ping Zeng; Yu-Hui Hao; Cong Liu; Jing Liu; Wei-Dong Wang; Rong Li
Journal:  ACS Appl Mater Interfaces       Date:  2015-10-20       Impact factor: 9.229

Review 4.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.

Authors:  Andreas Wicki; Dominik Witzigmann; Vimalkumar Balasubramanian; Jörg Huwyler
Journal:  J Control Release       Date:  2014-12-26       Impact factor: 9.776

5.  Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice.

Authors:  Leyang Zhang; Yong Hu; Xiqun Jiang; Changzheng Yang; Wei Lu; Yong Hua Yang
Journal:  J Control Release       Date:  2004-04-16       Impact factor: 9.776

6.  A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.

Authors:  Quanbing Mou; Yuan Ma; Xinyuan Zhu; Deyue Yan
Journal:  J Control Release       Date:  2016-03-31       Impact factor: 9.776

7.  Rodlike MSN@Au Nanohybrid-Modified Supermolecular Photosensitizer for NIRF/MSOT/CT/MR Quadmodal Imaging-Guided Photothermal/Photodynamic Cancer Therapy.

Authors:  Shan Yang; Qing You; Lifang Yang; Peishan Li; Qianglan Lu; Siyu Wang; Fengping Tan; Yanhui Ji; Nan Li
Journal:  ACS Appl Mater Interfaces       Date:  2019-02-05       Impact factor: 9.229

8.  Identification of ROS using oxidized DCFDA and flow-cytometry.

Authors:  Evgeniy Eruslanov; Sergei Kusmartsev
Journal:  Methods Mol Biol       Date:  2010

9.  Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies.

Authors:  Hanmei Bao; Qing Zhang; Hui Xu; Zhao Yan
Journal:  Int J Nanomedicine       Date:  2016-03-07

10.  Chlorins e6 loaded silica nanoparticles coated with gastric cancer cell membrane for tumor specific photodynamic therapy of gastric cancer.

Authors:  Jiaxing Yang; Yongliang Teng; Yu Fu; Chunyu Zhang
Journal:  Int J Nanomedicine       Date:  2019-07-09
View more
  2 in total

1.  Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.

Authors:  Linming Li; Yan Chen; Qingpeng Wang; Zuojie Li; Zhifang Liu; Xuewen Hua; Jun Han; Chunxiao Chang; Zhengping Wang; Dacheng Li
Journal:  Int J Nanomedicine       Date:  2021-08-14

Review 2.  Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin.

Authors:  Yukun Chen; Zhenzhi Wang; Xiaofan Wang; Mingliang Su; Fan Xu; Lian Yang; Lijun Jia; Zhanxia Zhang
Journal:  Int J Nanomedicine       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.